Cargando…
MiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver
PURPOSE: This research was designed to investigate how miR-542-5p regulates the progression of hyperglycemia and hyperlipoidemia. MATERIALS AND METHODS: An in vivo model with diabetic db/db mice and an in vitro model with forskolin/dexamethasone (FSK/DEX)-induced primary hepatocytes and HepG2 cells...
Autores principales: | Tian, Fang, Ying, Hui-Min, Wang, Yuan-Yuan, Cheng, Bo-Ning, Chen, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471073/ https://www.ncbi.nlm.nih.gov/pubmed/32882762 http://dx.doi.org/10.3349/ymj.2020.61.9.780 |
Ejemplares similares
-
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
por: Unterbruner, Kristoffer, et al.
Publicado: (2018) -
Protective effect of the daming capsule on impaired baroreflexes in STZ-induced diabetic rats with hyperlipoidemia
por: Ai, Jing, et al.
Publicado: (2010) -
Micro-RNA miR-542-3p suppresses decidualization by targeting ILK pathways in human endometrial stromal cells
por: Qu, Xinlan, et al.
Publicado: (2021) -
Pristimerin inhibits glioma progression by targeting AGO2 and PTPN1 expression via miR-542-5p
por: Li, Zaiyu, et al.
Publicado: (2019) -
Pristimerin Suppressed Breast Cancer Progression via miR-542-5p/DUB3 Axis
por: Cheng, Shihuan, et al.
Publicado: (2020)